Huapont Life Sciences Co., Ltd. (002004.SZ)
CNY 3.9
(3.17%)
CNY 3.9
(3.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.12 Billion CNY | -28.19% |
| 2022 | 2.85 Billion CNY | 30.75% |
| 2021 | 2.49 Billion CNY | 8.42% |
| 2020 | 2.42 Billion CNY | -0.12% |
| 2019 | 2.32 Billion CNY | 3.4% |
| 2018 | 2.29 Billion CNY | 54.58% |
| 2017 | 1.52 Billion CNY | 1.31% |
| 2016 | 1.4 Billion CNY | 4.77% |
| 2015 | 1.36 Billion CNY | 42.55% |
| 2014 | 923.24 Million CNY | 61.23% |
| 2013 | 612.81 Million CNY | 11.06% |
| 2012 | 639.89 Million CNY | 51.61% |
| 2011 | 377.73 Million CNY | 80.17% |
| 2010 | 196.15 Million CNY | 28.81% |
| 2009 | 160.1 Million CNY | -3.82% |
| 2008 | 165.83 Million CNY | -42.51% |
| 2007 | 289.14 Million CNY | 246.21% |
| 2006 | 83.63 Million CNY | 10.85% |
| 2005 | 75.45 Million CNY | 9.96% |
| 2004 | 68.62 Million CNY | 21.22% |
| 2003 | 56.57 Million CNY | 13.29% |
| 2002 | 49.96 Million CNY | 37.53% |
| 2001 | 36.33 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 300.58 Million CNY | -16.71% |
| 2024 Q1 | 369.65 Million CNY | 119.87% |
| 2024 Q2 | 374.31 Million CNY | -35.03% |
| 2023 FY | - CNY | -28.19% |
| 2023 Q4 | 252.62 Million CNY | -33.0% |
| 2023 Q3 | 377.06 Million CNY | -26.25% |
| 2023 Q2 | 511.29 Million CNY | 14.07% |
| 2023 Q1 | 448.23 Million CNY | 6.52% |
| 2022 FY | - CNY | 30.75% |
| 2022 Q1 | 590.84 Million CNY | -8.15% |
| 2022 Q2 | 941.01 Million CNY | 59.27% |
| 2022 Q3 | 701.19 Million CNY | -25.49% |
| 2022 Q4 | 420.81 Million CNY | -39.99% |
| 2021 Q3 | 416.78 Million CNY | -14.75% |
| 2021 Q4 | 643.28 Million CNY | 54.35% |
| 2021 Q2 | 488.88 Million CNY | 41.73% |
| 2021 Q1 | 344.93 Million CNY | -18.4% |
| 2021 FY | - CNY | 8.42% |
| 2020 Q1 | 288.05 Million CNY | -36.09% |
| 2020 FY | - CNY | -0.12% |
| 2020 Q3 | 499.68 Million CNY | -5.3% |
| 2020 Q4 | 422.69 Million CNY | -15.41% |
| 2020 Q2 | 527.65 Million CNY | 83.18% |
| 2019 Q3 | 549.64 Million CNY | 9.25% |
| 2019 FY | - CNY | 3.4% |
| 2019 Q1 | 339 Million CNY | 9.5% |
| 2019 Q2 | 503.08 Million CNY | 48.4% |
| 2019 Q4 | 450.71 Million CNY | -18.0% |
| 2018 Q2 | 510.76 Million CNY | 33.61% |
| 2018 FY | - CNY | 54.58% |
| 2018 Q4 | 309.58 Million CNY | -43.94% |
| 2018 Q3 | 552.24 Million CNY | 8.12% |
| 2018 Q1 | 382.28 Million CNY | -24.4% |
| 2017 Q1 | 229.49 Million CNY | -41.3% |
| 2017 FY | - CNY | 1.31% |
| 2017 Q4 | 505.63 Million CNY | 270.54% |
| 2017 Q2 | 420.38 Million CNY | 83.18% |
| 2017 Q3 | 136.45 Million CNY | -67.54% |
| 2016 Q2 | 460.48 Million CNY | 94.67% |
| 2016 FY | - CNY | 4.77% |
| 2016 Q4 | 390.93 Million CNY | 27.72% |
| 2016 Q3 | 306.08 Million CNY | -33.53% |
| 2016 Q1 | 236.55 Million CNY | -30.81% |
| 2015 FY | - CNY | 42.55% |
| 2015 Q4 | 341.88 Million CNY | 32.74% |
| 2015 Q3 | 257.55 Million CNY | -34.47% |
| 2015 Q2 | 393.02 Million CNY | 58.87% |
| 2015 Q1 | 247.38 Million CNY | -20.53% |
| 2014 Q4 | 311.3 Million CNY | 124.86% |
| 2014 Q1 | 144.94 Million CNY | 74.02% |
| 2014 FY | - CNY | 61.23% |
| 2014 Q2 | 251.17 Million CNY | 73.3% |
| 2014 Q3 | 138.44 Million CNY | -44.88% |
| 2013 Q3 | 125.93 Million CNY | -22.94% |
| 2013 Q2 | 163.41 Million CNY | 50.72% |
| 2013 Q1 | 108.41 Million CNY | -44.34% |
| 2013 Q4 | 83.28 Million CNY | -33.86% |
| 2013 FY | - CNY | 11.06% |
| 2012 Q4 | 194.78 Million CNY | 33.47% |
| 2012 Q3 | 145.93 Million CNY | 262.3% |
| 2012 Q2 | 40.28 Million CNY | -45.49% |
| 2012 Q1 | 73.89 Million CNY | -68.0% |
| 2012 FY | - CNY | 51.61% |
| 2011 Q4 | 230.96 Million CNY | 394.4% |
| 2011 Q1 | 15.32 Million CNY | -84.44% |
| 2011 Q2 | 39.38 Million CNY | 157.02% |
| 2011 FY | - CNY | 80.17% |
| 2011 Q3 | 46.71 Million CNY | 18.62% |
| 2010 Q1 | 17.83 Million CNY | -51.3% |
| 2010 Q2 | 27.01 Million CNY | 51.41% |
| 2010 Q3 | 26.24 Million CNY | -2.84% |
| 2010 Q4 | 98.47 Million CNY | 275.22% |
| 2010 FY | - CNY | 28.81% |
| 2009 Q4 | 36.63 Million CNY | 46.69% |
| 2009 Q3 | 24.97 Million CNY | -66.47% |
| 2009 Q2 | 74.48 Million CNY | 484.53% |
| 2009 Q1 | 12.74 Million CNY | -68.94% |
| 2009 FY | - CNY | -3.82% |
| 2008 Q3 | 35.24 Million CNY | 21.35% |
| 2008 Q2 | 29.04 Million CNY | 28.48% |
| 2008 Q1 | 22.6 Million CNY | -87.5% |
| 2008 Q4 | 41.02 Million CNY | 16.41% |
| 2008 FY | - CNY | -42.51% |
| 2007 Q1 | -24.78 Million CNY | -190.68% |
| 2007 FY | - CNY | 246.21% |
| 2007 Q4 | 180.78 Million CNY | 363.98% |
| 2007 Q3 | 38.96 Million CNY | -69.36% |
| 2007 Q2 | 127.14 Million CNY | 613.04% |
| 2006 Q2 | 11.19 Million CNY | -15.65% |
| 2006 Q1 | 13.27 Million CNY | -30.76% |
| 2006 FY | - CNY | 10.85% |
| 2006 Q4 | 27.33 Million CNY | -17.01% |
| 2006 Q3 | 32.93 Million CNY | 194.08% |
| 2005 Q1 | 9.28 Million CNY | -59.96% |
| 2005 Q4 | 19.17 Million CNY | -35.41% |
| 2005 FY | - CNY | 9.96% |
| 2005 Q3 | 29.68 Million CNY | 58.62% |
| 2005 Q2 | 18.71 Million CNY | 101.65% |
| 2004 Q4 | 23.17 Million CNY | 60.76% |
| 2004 Q2 | 19 Million CNY | 115.52% |
| 2004 FY | - CNY | 21.22% |
| 2004 Q1 | 8.81 Million CNY | -25.12% |
| 2004 Q3 | 14.41 Million CNY | -24.13% |
| 2003 Q4 | 11.77 Million CNY | -10.04% |
| 2003 FY | - CNY | 13.29% |
| 2003 Q3 | 13.09 Million CNY | 0.0% |
| 2002 FY | - CNY | 37.53% |
| 2001 FY | - CNY | 0.0% |